197 related articles for article (PubMed ID: 29691261)
1. Serum vancomycin concentrations after oral and intracolonic vancomycin administration in a patient with colonic discontinuity and severe
Wilke K; Helbig S; de With K
Am J Health Syst Pharm; 2018 May; 75(9):e189-e193. PubMed ID: 29691261
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection.
Pettit NN; DePestel DD; Fohl AL; Eyler R; Carver PL
Pharmacotherapy; 2015 Feb; 35(2):119-26. PubMed ID: 25689243
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series.
Akamine CM; Ing MB; Jackson CS; Loo LK
BMC Infect Dis; 2016 Jul; 16():316. PubMed ID: 27388627
[TBL] [Abstract][Full Text] [Related]
4. Intracolonic Vancomycin Through Laprascopic Appendicostomy for Treatment of Severe Clostridium difficile Colitis Does Not Get Systemic Absorption.
Alhazmi L; Almeshal N; Assaly R
Am J Ther; 2017; 24(5):e616. PubMed ID: 28301334
[No Abstract] [Full Text] [Related]
5. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
Rao S; Kupfer Y; Pagala M; Chapnick E; Tessler S
Scand J Infect Dis; 2011 May; 43(5):386-8. PubMed ID: 21198337
[TBL] [Abstract][Full Text] [Related]
6. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
[TBL] [Abstract][Full Text] [Related]
7. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
8. Impact of vancomycin faecal concentrations on clinical and microbiological outcomes in Clostridium difficile infection.
Thabit AK; Nicolau DP
Int J Antimicrob Agents; 2015 Aug; 46(2):205-8. PubMed ID: 26055927
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Rectal Vancomycin Irrigation for Treatment of
Feeney ME; Thompson M; Gerlach AT; Rushing A; Evans DC; Eiferman DS; Murphy CV
Surg Infect (Larchmt); 2019 Jul; 20(5):411-415. PubMed ID: 30900947
[No Abstract] [Full Text] [Related]
10. Intracolonic administration of vancomycin for Clostridium difficile infection.
Grimm M; Rafael T
Nursing; 2014 Sep; 44(9):58-60. PubMed ID: 25140945
[No Abstract] [Full Text] [Related]
11. Vancomycin Enema in the Treatment of
Fawley J; Napolitano LM
Surg Infect (Larchmt); 2019; 20(4):311-316. PubMed ID: 30716016
[No Abstract] [Full Text] [Related]
12. Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
Chihara S; Shimizu R; Furukata S; Hoshino K
Scand J Infect Dis; 2011 Feb; 43(2):149-50. PubMed ID: 20831355
[TBL] [Abstract][Full Text] [Related]
13. Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case.
Nathanson DR; Sheahan M; Chao L; Wallack MK
Dis Colon Rectum; 2001 Dec; 44(12):1871-2. PubMed ID: 11742178
[TBL] [Abstract][Full Text] [Related]
14. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
15. SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.
Sattar A; Thommes P; Payne L; Warn P; Vickers RJ
J Antimicrob Chemother; 2015; 70(6):1757-62. PubMed ID: 25652749
[TBL] [Abstract][Full Text] [Related]
16. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
Lam SW; Bass SN; Neuner EA; Bauer SR
Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity Reaction Following Administration of Low-Dose Oral Vancomycin for the Treatment of Clostridium difficile in a Patient With Normal Renal Function.
Baumgartner LJ; Brown L; Geier C
J Pharm Pract; 2017 Dec; 30(6):650-652. PubMed ID: 27630210
[TBL] [Abstract][Full Text] [Related]
18. Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection.
Crawford T; Huesgen E; Danziger L
Am J Health Syst Pharm; 2012 Jun; 69(11):933-43. PubMed ID: 22610025
[TBL] [Abstract][Full Text] [Related]
19. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
20. Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.
Gonzales M; Pepin J; Frost EH; Carrier JC; Sirard S; Fortier LC; Valiquette L
BMC Infect Dis; 2010 Dec; 10():363. PubMed ID: 21192802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
